Zirconate and titanate pyrochlores were subjected to 1 MeV of Kr+ irradiation. Pyrochlores in the Gd2(ZrxTi1-x)2O7 system (x = 0, 0.25, 0.5, 0.75, 1) showed a systematic change in the susceptibility to radiation-induced amorphization with increasing Zr content. Gd2Ti2O7 amorphized at relatively low dose (0.2 displacement per atom at room temperature), and the critical temperature for amorphization was 1100 K. With increasing zirconium content, the pyrochlores became increasingly radiation resistant, as demonstrated by the increasing dose and decreasing critical temperature for amorphization. Pyrochlores highly-enriched in Zr (Gd2Zr2O7, Gd2Zr1.8Mg0.2O6.8, Gd1.9Sr0.1Zr1.9Mg0.1O6.85, and Gd1.9Sr0.1Zr1.8Mg0.2O6.75) could not be amorphized, even at temperature as low as 25 K.
The room-temperature tetragonal-to-cubic transformation in BaTiO, powders with decreasing particle size has been carefully studied, using materials prepared mainly by hydrothermal methods. Hydrothermal BaTiO, powders exhibited a more uniform particle size distribution than oxalate-route powders, with X-ray diffraction and electron microscopy indicating that powders 50.19 pm in size were fully cubic while powders 20.27 pm were completely tetragonal (within a 5% detection limit for cubic material) at room temperature. The tetragonal-to-cubic transformation temperature was also found to lie in the range of 121" -C 3°C for BaTiO, powders with room-temperature (c/a) values > 1.008. No transformation could be detected using differential scanning calorimetry for BaTiO, particles with a (cla) c 1.008 at room temperature. BaTiO, powder with a particle size just too small (0.19 pm) to be tetragonal at room temperature remained cubic down to 80 K. Different models for the cubic-to-tetragonal room-temperature transformation are discussed. Hydroxyl ions do not appear to greatly affect the cubic-to-tetragonal transformation, which appears to be essentially dependent on particle size. It is concluded that a model based on surface free energy, as previously discussed for the monoclinic-to-tetragonal transformation at room temperature of fine ZrO, particles, is consistent with the experimental data.
The Gd2(Ti1
-
y
Zr
y
)2O7 pyrochlore series undergoes a structural phase transition from pyrochlore (Fd3̄m) to
defect fluorite (Fm3̄m) that can be driven compositionally by increasing the Zr content or thermally by sintering
Zr-rich compositions at temperatures above 1550 °C. Our results demonstrate that ion-beam irradiation can
also drive the structural phase transition for Zr-rich compositions. In an effort to understand the effects of
composition and ion-beam irradiation on this phase transition, powder X-ray diffraction, polarized Raman,
reflection infrared, and X-ray absorption spectroscopy experiments were conducted on Gd2(Ti1
-
y
Zr
y
)2O7
pyrochlores prior to and following irradiation with 2 MeV Au2+ ions to a fluence of 5 ions/nm2. Analysis of
the vibrational and X-ray absorption data suggests that the structural integrity of the pyrochlore structure is
based on distorted corner-shared TiO6 or ZrO6 octahedra. The vibrational spectra indicate that both anion and
cation disorder precede the compositionally driven phase transition, but cation disorder appears to dominate
the irradiation-driven transition. Analyses of the extended X-ray absorption fine structure of the Ti and Zr K
edges and the Gd LIII edges reveal a significant change in the Gd local environment upon irradiation and with
increasing Zr content. The Ti and Zr local environments are less affected by irradiation or compositional
change but show evidence of increasing disorder that can be attributed to rotations about shared polyhedral
edges and corners.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.